NXPZ-2

• CAT Number: I043494
• CAS Number: 2254492-08-3
• Molecular Formula: C27H27N5O7S2
• Molecular Weight: 597.66
• Purity: ≥95%
• Synonyms: 2-[[4-[(2-amino-2-oxoethyl)-(4-methoxyphenyl)sulfonylamino]naphthalen-1-yl]-(4-aminophenyl)sulfonylamino]acetamide
• InChI: InChI=1S/C27H27N5O7S2/c1-39-19-8-12-21(13-9-19)41(37,38)32(17-27(30)34)25-15-14-24(22-4-2-3-5-23(22)25)31(16-26(29)33)40(35,36)20-10-6-18(28)7-11-20/h2-15H,16-17,28H2,1H3,(H2,29,33)(H2,30,34)
• InChIKey: DFIZGWXPFCOCFG-UHFFFAOYSA-N
• SMILES: COC1=CC=C(C=C1)S(=O)(=O)N(CC(=O)N)C2=CC=C(C3=CC=CC=C32)N(CC(=O)N)S(=O)(=O)C4=CC=C(C=C4)N

NXPZ-2（Cat No.:I043494）is a small-molecule compound under investigation for its potential in cancer therapy. It acts by selectively targeting specific proteins involved in the growth and survival of cancer cells. By modulating key signaling pathways, NXPZ-2 disrupts tumor progression, making it a promising candidate for treating various cancers. The compound has been studied for its ability to inhibit cancer cell proliferation and induce apoptosis (programmed cell death). Ongoing preclinical and clinical trials are evaluating NXPZ-2’s efficacy, safety, and potential as a therapeutic agent in oncology, particularly for resistant or aggressive cancers.